CDKN2A and head and neck squamous cell carcinoma: In view of this fact, the present study was conducted to investigate the microRNA targeting CDKN2A gene, which revealed one key microRNA viz., hsa-miR-542 that can be further developed as a prognostic, diagnostic or therapeutic lead for HNSCC.